Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Mr. Sofiane FahmyHead of Europe | -62,33k | 3,00M | Vente | 48,20 | 78,91k | -44,13% |
| 2026-05-07 | Mr. Sofiane FahmyHead of Europe | -62,33k | 3,00M | Vente | 48,20 | 78,91k | -44,13% |
| 2026-05-05 | Mr. Norbert OppitzHead of International | -12,00k | 563,16k | Vente | 46,93 | 50,13k | -19,32% |
| 2026-05-05 | Dr. Guido OelkersCEO & President | -40,99k | 1,92M | Vente | 46,77 | 607,80k | -6,32% |
| 2026-02-25 | Ms. Filippa StenbergIndependent Director | 2,40k | 108,34k | Achat | 45,14 | 571,00 | -131,22% |
| 2025-10-31 | Dr. Guido OelkersCEO & President | -70,00k | 2,42M | Vente | 34,53 | 607,80k | -10,33% |
| 2025-10-29 | Dr. Guido OelkersCEO & President | -80,00k | 2,78M | Vente | 34,71 | 607,80k | -11,63% |
| 2025-10-29 | Mr. Torbjörn HallbergGeneral Counsel & Head of Legal Affairs | -58,23k | 2,02M | Vente | 34,71 | 50,49k | -53,56% |
| 2025-10-28 | Mr. Daniel RankinHead of Strategy & Corporate Development | -69,92k | 2,43M | Vente | 34,47 - 34,77 | 8,50k | -89,16% |
| 2025-10-29 | Mr. Norbert OppitzHead of International | -114,64k | 3,97M | Other Disposition | 34,60 | 62,13k | -64,85% |
| 2025-10-24 | Dr. Guido OelkersCEO & President | -80,00k | 2,70M | Vente | 33,73 | 607,80k | -11,63% |
| 2025-10-23 | Dr. Guido OelkersCEO & President | -100,00k | 3,32M | Vente | 33,20 | 607,80k | -14,13% |
| 2025-10-22 | Ms. Lydia Abad-FranchSenior VP, Head of R&D & Medical Affairs and Chief Medical Officer | -56,03k | 1,88M | Vente | 33,56 - 33,58 | 10,22k | -84,58% |
| 2025-10-22 | Mr. Henrik StenqvistCFO | -65,84k | 2,20M | Vente | 33,41 | 95,82k | -40,72% |
| 2025-10-21 | Mr. Duane H. BarnesHead of North America | -103,02k | 3,41M | Vente | 33,14 | 32,72k | -75,89% |
| 2025-10-22 | Mr. Mahmood LadhaHead of Strategic Transformation Operations | -68,10k | 2,29M | Vente | 33,59 | 28,77k | -70,30% |
| 2025-08-12 | Katy MazibukoEmployee Representative Director | 90,00 | 2,60k | Achat | 28,85 | 4,45k | 2,06% |
| 2025-07-29 | Mr. Duane H. BarnesHead of North America | -3,59k | 110,34k | Vente | 30,75 | 32,72k | -9,88% |
| 2025-07-16 | Dr. Sven Anders UllmanInitié | -7,72k | 230,30k | Vente | 29,82 | 3,43k | -69,25% |
| 2025-06-10 | Mr. Duane H. BarnesHead of North America | -11,73k | 362,07k | Vente | 30,87 | 32,72k | -26,39% |
| 2025-06-10 | Mr. Mahmood LadhaHead of Strategic Transformation Operations | -7,31k | 225,78k | Vente | 30,87 | 28,77k | -20,27% |
| 2025-06-10 | Mr. Daniel RankinHead of Strategy & Corporate Development | -7,39k | 228,25k | Vente | 30,87 | 15,47k | -32,34% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.